Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycosis fungoides: disease evolution of the "lion queen" revisited.
Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Lombardo GA, Rupoli S, Alaibac M, Arcaini L, Bagnato S, Baldo A, Bottoni U, Carbone A, Cestari R Clerico R, De Renzo A, Fava P, Fierro MT, Filotico R, Fimiani M, Frontani M Girgenti V, Goteri G, Leali C, Mamusa AM, Mariotti G, Mastrandrea V, Pellegrini C, Pennese E, Pileri A, Savoia P, Stelitano C, Titli S, Virgili A, Zichichi L, Zinzani PL, Bernengo MG. Quaglino P, et al. Among authors: goteri g. G Ital Dermatol Venereol. 2012 Dec;147(6):523-31. G Ital Dermatol Venereol. 2012. PMID: 23149698 Review.
Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
Rupoli S, Goteri G, Pulini S, Filosa A, Tassetti A, Offidani M, Filosa G, Mozzicafreddo G, Giacchetti A, Brandozzi G, Cataldi I, Barulli S, Ranaldi R, Scortechini AR, Capretti R, Fabris G, Leoni P; Marche Regional Multicentric Study Group of Cutaneous Lymphomas. Rupoli S, et al. Among authors: goteri g. Eur J Haematol. 2005 Aug;75(2):136-45. doi: 10.1111/j.1600-0609.2005.00497.x. Eur J Haematol. 2005. PMID: 16000130 Clinical Trial.
Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Tassetti A, Scortechini AR, Offidani M, Mulattieri S, Stronati A, Brandozzi G, Giacchetti A, Mozzicafreddo G, Ricotti G, Filosa G, Bettacchi A, Simonacci M, Novelli N, Leoni P. Pulini S, et al. Among authors: goteri g. Haematologica. 2007 May;92(5):686-9. doi: 10.3324/haematol.10879. Haematologica. 2007. PMID: 17488695 Free article. Clinical Trial.
Prognostic markers in mycosis fungoides.
Goteri G, Rupoli S, Pulini S, Tassetti A, Leoni P. Goteri G, et al. Anal Quant Cytol Histol. 2008 Aug;30(4):187-9. Anal Quant Cytol Histol. 2008. PMID: 18773735 No abstract available.
Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.
Goteri G, Rupoli S, Campanati A, Zizzi A, Picardi P, Cardelli M, Giantomassi F, Canafoglia L, Marchegiani F, Mozzicafreddo G, Brandozzi G, Stramazzotti D, Ganzetti G, Lisa R, Simonetti O, Offidani A, Federici I, Filosa G, Leoni P. Goteri G, et al. Br J Dermatol. 2012 May;166(5):948-52. doi: 10.1111/j.1365-2133.2012.10818.x. Br J Dermatol. 2012. PMID: 22233400
Combination treatment in CTCL: the current role of bexarotene.
Delfino C, Grandi V, Pileri A, Rupoli S, Quaglino P, Alterini R, Goteri G, Canafoglia L, Pimpinelli N. Delfino C, et al. Among authors: goteri g. G Ital Dermatol Venereol. 2012 Dec;147(6):573-80. G Ital Dermatol Venereol. 2012. PMID: 23149703
Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.
Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N. Rupoli S, et al. Among authors: goteri g. Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672. Eur J Dermatol. 2016. PMID: 26678311 Clinical Trial.
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, Goteri G, Tomasini C, Quaglino P, Riboni R, Arra M, Dallera E, Grandi V, Alaibac M, Ramponi A, Rattotti S, Cabras MG, Franceschetti S, Fraternali-Orcioni G, Zerbinati N, Onida F, Ascani S, Fierro MT, Rupoli S, Gambacorta M, Zinzani PL, Pimpinelli N, Santucci M, Paulli M. Lucioni M, et al. Among authors: goteri g. Cancer Med. 2016 Oct;5(10):2740-2755. doi: 10.1002/cam4.865. Epub 2016 Sep 26. Cancer Med. 2016. PMID: 27665744 Free PMC article.
Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
Lucioni M, Pescia C, Bonometti A, Fraticelli S, Moltrasio C, Ramponi A, Riboni R, Roccio S, Ferrario G, Arcaini L, Goteri G, Berti E, Paulli M. Lucioni M, et al. Among authors: goteri g. Hum Pathol. 2021 May;111:1-9. doi: 10.1016/j.humpath.2021.01.006. Epub 2021 Feb 3. Hum Pathol. 2021. PMID: 33548250
173 results